Non-invasive prenatal diagnostics of aneuploidy using next-generation DNA sequencing technologies, and clinical considerations

Clinical Chemistry and Laboratory Medicine

Volumn 51, Issue 6, 2013, Pages 1141-1154

  Nepomnyashchaya, Yana N ^a   Artemov, Artem V ^a   Roumiantsev, Sergey A ^a   Roumyantsev, Alexander G ^a   Zhavoronkov, Alex ^a,b  

^a Federal Research Center of Pediatric Hematology Oncology and Immunology   (Russian Federation)

^b Biogerontology Research Foundation   (United Kingdom)

Author keywords

Aneuploidy; Cell free fetal DNA; Down syndrome; Fetal aneuploidies; Next generation sequencing; Non invasive prenatal diagnosis; Prenatal screening

Indexed keywords

REAGENT;

ALGORITHM; ANEUPLOIDY; CHROMOSOME ABERRATION; COST; DNA SEQUENCE; GENETIC DISORDER; GENOME; HUMAN; NON INVASIVE PROCEDURE; PERFORMANCE; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; REVIEW; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ALGORITHMS; ANEUPLOIDY; DNA; FEMALE; GENETIC TESTING; HUMANS; PREGNANCY; PRENATAL DIAGNOSIS; SEQUENCE ANALYSIS, DNA;

EID: 84882307134     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2012-0281     Document Type: Review

References (55)

1. ACOG. ACOG Practice Bulletin No. 88, December 2007. Invasive prenatal testing for aneuploidy. Obstet Gynecol 2007;110:1459-67.
2. Lo YM, Corbetta N, Chamberlain PF, Rai V, Sargent IL, Redman CW, et al. Presence of fetal DNA in maternal plasma and serum. Lancet 1997;350:485-7.
3. Fan HC, Quake SR. Detection of aneuploidy with digital polymerase chain reaction. Anal Chem 2007;79:7576-9.
4. Lo YM, Lun FM, Chan KC, Tsui NB, Chong KC, Lau TK, et al. Digital PCR for the molecular detection of fetal chromosomal aneuploidy. Proc Natl Acad Sci USA 2007;104:13116-21.
5. Fan HC, Blumenfeld YJ, El-Sayed YY, Chueh J, Quake SR. Microfluidic digital PCR enables rapid prenatal diagnosis of fetal aneuploidy. Am J Obstet Gynecol 2009;200:e541-9.
6. Chan KC, Zhang J, Hui AB, Wong N, Lau TK, Leung TN, et al. Size distributions of maternal and fetal DNA in maternal plasma. Clin Chem 2004;50:88-92.
7. Li Y, Zimmermann B, Rusterholz C, Kang A, Holzgreve W, Hahn S. Size separation of circulatory DNA in maternal plasma permits ready detection of fetal DNA polymorphisms. Clin Chem 2004;50:1002-11.
8. Alberry M, Maddocks D, Jones M, Abdel Hadi M, Abdel-Fattah S, Avent N, et al. Free fetal DNA in maternal plasma in anembryonic pregnancies: confirmation that the origin is the trophoblast. Prenat Diagn 2007;27:415-8.
9. Lun FM, Chiu RW, Chan KC, Leung TY, Lau TK, Lo YM. Microfluidics digital PCR reveals a higher than expected fraction of fetal DNA in maternal plasma. Clin Chem 2008;54:1664-72.
10. Lo YM, Zhang J, Leung TN, Lau TK, Chang AM, Hjelm NM. Rapid clearance of fetal DNA from maternal plasma. Am J Hum Genet 1999;64:218-24.
11. Lo YM, Chan KC, Sun H, Chen EZ, Jiang P, Lun FM, et al. Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus. Sci Transl Med 2010;2:61ra91.
12. Metzker ML. Sequencing technologies-the next generation. Nat Rev Genet 2010;11:31-46.
13. Kitzman JO, Snyder MW, Ventura M, Lewis AP, Qiu R, Simmons LE, et al. Noninvasive whole-genome sequencing of a human fetus. Sci Transl Med 2012;4:137ra76.
14. Fan HC, Blumenfeld YJ, Chitkara U, Hudgins L, Quake SR. Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood. Proc Natl Acad Sci USA 2008;105:16266-71.
15. Chiu RW, Chan KC, Gao Y, Lau VY, Zheng W, Leung TY, et al. Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma. Proc Natl Acad Sci USA 2008;105:20458-63.
16. Bianchi DW, Platt LD, Goldberg JD, Abuhamad AZ, Sehnert AJ, Rava RP. Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. Obstet Gynecol 2012;119:890-901.
17. Palomaki GE, Deciu C, Kloza EM, Lambert-Messerlian GM, Haddow JE, Neveux LM, et al. DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study. Genet Med 2012;3:296-305.
18. Rabinowitz M, Gemelos G, Banjevic M, Ryan A, Demko Z, Hill M, et al. Methods for non-invasive prenatal ploidy calling. Patent 2011; App: US 2011/0288780.
19. Sparks AB, Wang ET, Struble CA, Barrett W, Stokowski R, McBride C, et al. Selective analysis of cell-free DNA in maternal blood for evaluation of fetal trisomy. Prenat Diagn 2012;32:3-9.
20. Sparks AB, Struble CA, Wang ET, Song K, Oliphant A. Non-invasive prenatal detection and selective analysis of cell-free DNA obtained from maternal blood: evaluation for trisomy 21 and trisomy 18. Am J Obstet Gynecol 2012;206:319.e1-9.
21. Wright D, Spencer K, Kagan KK, Tørring N, Petersen OB, Christou A, et al. First-trimester combined screening for trisomy 21 at 7-14 weeks' gestation. Ultrasound Obstet Gynecol 2010;36:404-11.
22. Wilson RD. Amniocentesis and chorionic villus sampling. Curr Opin Obstet Gynecol 2000;12:810-6.
23. Mujezinovic F, Alfirevic Z. Procedure-related complications of amniocentesis and chorionic villous sampling: a systematic review. Obstet Gynecol 2007;110:687-94.
24. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, et al. Initial sequencing and analysis of the human genome. Nature 2001;409:860-921.
25. Chiu RW, Sun H, Akolekar R, Clouser C, Lee C, McKernan K, et al. Maternal plasma DNA analysis with massively parallel sequencing by ligation for noninvasive prenatal diagnosis of trisomy 21. Clin Chem 2010;56:459-63.
26. Fan HC, Quake SR. Sensitivity of noninvasive prenatal detection of fetal aneuploidy from maternal plasma using shotgun sequencing is limited only by counting statistics. PLoS One 2010;5:e10439.
27. Chen EZ, Chiu RW, Sun H, Akolekar R, Chan KC, Leung TY, et al. Noninvasive prenatal diagnosis of fetal trisomy 18 and trisomy 13 by maternal plasma DNA sequencing. PLoS One 2011;6:e21791.
28. Sehnert AJ, Rhees B, Comstock D, De Feo E, Heilek G, Burke J, et al. Optimal detection of fetal chromosomal abnormalities by massively parallel DNA sequencing of cell-free fetal DNA from maternal blood. Clin Chem 2011;57:1042-9.
29. Lo YM, Tein MS, Lau TK, Haines CJ, Leung TN, Poon PM, et al. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet 1998;62:768-75.
30. Samura O, Miharu N, Hyodo M, Honda H, Ohashi Y, Honda N, et al. Cell-free fetal DNA in maternal circulation after amniocentesis. Clin Chem 2003;49:1193-5.
31. Ehrich M, Deciu C, Zwiefelhofer T, Tynan JA, Cagasan L, Tim R, et al. Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting. Am J Obstet Gynecol 2011;204:205.e1-11.
32. Chiu RW, Akolekar R, Zheng YW, Leung T Y, Sun H, Chan KC, et al. Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study. Br Med J 2011;342:c7401.
33. Palomaki GE, Kloza EM, Lambert-Messerlian GM, Haddow JE, Neveux LM, Ehrich M, et al. DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study. Genet Med 2011;13:913-20.
34. Liao GJ, Lun FM, Zheng YW, Chan KC, Leung TY, Lau TK, et al. Targeted massively parallel sequencing of maternal plasma DNA permits efficient and unbiased detection of fetal alleles. Clin Chem 2011;57:92-101.
35. Gnirke A, Melnikov A, Maguire J, Rogov P, Le Proust EM, Brockman W, et al. Solution hybrid selection with ultra-long oligonucleotides for massively parallel targeted sequencing. Nat Biotech 2009;27:82-189.
36. Porreca GJ, Zhang K, Li JB, Xie B, Austin D, Vassallo SL, et al. Multiplex amplification of large sets of human exons. Nat Methods 2007;4:931-6.
37. Turner EH, Lee C, Ng SB, Nickerson DA, Shendure J. Massively parallel exon capture and library-free resequencing across 16 genomes. Nat Methods 2009;6:315-6.
38. Natera, Inc. Available from: http://natera.com. Accessed on 25 June 2012.
39. Dohm JC, Lottaz C, Borodina T, Himmelbauer H. Substantial biases in ultra-short read data sets from high-throughput DNA sequencing. Nucleic Acids Res 2008;36:e105.
40. Chiang DY, Getz G, Jaffe DB, O'Kelly MJ, Zhao X, Carter SL, et al. High resolution mapping of copy-number alterations with massively parallel sequencing. Nat Methods 2009;6:99-103.
41. Chu T, Bunce K, Hogge WA, Peters DG. Statistical model for whole genome sequencing and its application to minimally invasive diagnosis of fetal genetic disease. Bioinformatics 2009;25:1244-50.
42. Oliver JL, Carpena P, Roman-Roldan R, Mata-Balaguer T, Mejias-Romero A, Hackenberg M, et al. Isochore chromosome maps of the human genome. Gene 2002;300:117-27.
43. Canick JA, Kloza EM, Lambert-Messerlian GM, Haddow JE, Ehrich M, Van Den Boom D, et al. DNA sequencing of maternal plasma to identify Down syndrome and other trisomies in multiple gestations. Prenat Diagn 2012;32:740-4.
44. Sequenom, Inc. Available from: http://www.sequenom.com. Accessed on 25 June 2012.
45. Verinata Health, Inc. Available from: http://www.verinata.com Accessed on 25 June 2012.
46. Ariosa Diagnostics, Inc. Available from: http://www.ariadx.com. Accessed on 25 June 2012.
47. Canick J. Prenatal screening for trisomy 21:recent advances and guidelines. Clin Chem Lab Med 2011;50:1003-8.
48. Miao ZY, Liu X, Shi TK, Xu Y, Song QH, Tang SH. First trimester, second trimester, and integrated screening for Down's syndrome in China. J Med Screen 2012;19:68-71.
49. Boyd P, Rounding C, Chamberlain P, Wellesley D, Kurinczuk J. The evolution of prenatal screening and diagnosis and its impact on an unselected population over an 18-year period. BJOG 2012;119:1131-40.
50. Platt LD, Greene N, Johnson A, Zachary J, Thom E, Krantz D, et al. First trimester maternal serum biochemistry and fetal nuchal translucency screening (BUN) study group. Sequential pathways of testing after first-trimester screening for trisomy 21. Obstet Gynecol 2004;104:661-6.
51. Malone FD, Canick JA, Ball RH, Nyberg DA, Comstock CH, Bukowski R, et al. First-and second-trimester evaluation of risk (FASTER) research consortium. First-trimester or secondtrimester screening, or both, for Down's syndrome. N Engl J Med 2005;353:2001-11.
52. Crandall BF, Chua C. Detecting neural tube defects by amniocentesis between 11 and 15 weeks' gestation. Prenat Diagn 1995;15:339-43.
53. Barber R, Shalat S, Hendricks K, Joggerst B, Larsen R, Suarez L, et al. Investigation of folate pathway gene polymorphisms and the incidence of neural tube defects in a Texas hispanic population. Mol Genet Metab 2000;70:45-52.
54. Ashcroft R. What is clinical effectiveness ? Stud Hist Philos Biol Biomed Sci 2002;33:219-33.
55. Gray A. Critical appraisal of methods: economic evaluation. In: Dawes M, Davies P, Gray A, Mant J, Seers K, Snowball R, editors. Evidence-based practice: a primer for healthcare professionals, 2nd ed. London: Elsevier, 2005:121-33.